Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Women with pattern hair loss often have higher blood sugar, cholesterol, blood pressure, and waist size, suggesting a link between hair loss and metabolic syndrome.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Topical botanical lotion increases hair density and improves quality of life in women with hair loss.

No treatment fully stops excessive hair growth in women, but various methods can help manage it effectively.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

Effective treatments for common hair loss are limited and may have side effects, leading to patient disappointment and treatment discontinuation.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Hormonal birth control can cause skin issues, but low-dose options and those with antiandrogens may reduce these effects.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Longer CAG repeats in gene linked to more severe hair loss in females.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

Taking hormonal contraceptives can cause skin changes, including hair loss, due to the effects of synthetic sex hormones.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Cyproterone slightly inhibited hair growth in castrated mice, while tamoxifen significantly inhibited hair growth in castrated mice but not in normal mice.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.